(secondQuint)Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation.

 The objective is to provide access to everolimus for patients with Recurrent UPSC and limited treatment alternatives.

 Letrozole 2.

5mg daily q 30 days Everolimus 10mg daily q 28 days.

 Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation@highlight

This is an open-label treatment program following basic prescribing information for patients with recurrent UPSC (Uterine Papillary Serous Carcinoma) to provide access to everolimus and limited treatment alternatives.

